XTLB
XTL Biopharmaceuticals Ltd ADRNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$5.65M
P/E Ratio
—
EPS
$-3.60
Beta
0.68
52W High
$10.28
52W Low
$2.12
50-Day MA
$2.70
200-Day MA
$4.07
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
0.00
About XTL Biopharmaceuticals Ltd ADR
XTL Biopharmaceuticals Ltd., a biopharmaceutical company, is engaged in the acquisition and development of pharmaceutical products for the treatment of autoimmune diseases. The company is headquartered in Ramat Gan, Israel.
Fundamentals
| Revenue (TTM) | 968,000 |
| Gross Profit (TTM) | $-2.25M |
| EBITDA | $-1.97M |
| Operating Margin | -854.00% |
| Return on Equity | -577.00% |
| Return on Assets | -240.60% |
| Revenue/Share (TTM) | $0.40 |
| Book Value | $0.00 |
| Price-to-Book | 0.97 |
| Price-to-Sales (TTM) | 5.84 |
| EV/Revenue | 5.71 |
| EV/EBITDA | 16.88 |
| Quarterly Earnings Growth (YoY) | -76.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $2.37M |
| Float | $274.56M |
| % Insiders | 38.46% |
| % Institutions | 4.15% |
Historical Volatility
HV 10-Day
35.84%
HV 20-Day
52.97%
HV 30-Day
59.98%
HV 60-Day
84.71%
HV Rank
—
Volatility is currently contracting
Data last updated: 4/28/2026